Small children and pregnant women may be underdosed with widely used antimalarial drug

Current recommended treatment regimens for the most widely used medicine for uncomplicated Plasmodium falciparum malaria may be sub-optimal for small children and pregnant women according to a study led by Prof. Joel Tarning, Head of Pharmacometrics at the WorldWide Antimalarial Resistance Network (WWARN) & Head of Clinical Pharmacology at the Mahidol Oxford Tropical Medicine Research Network (MORU).